New timing strategy tested to boost chemo against advanced pancreatic cancer
Disease control
Recruiting now
This study is testing whether changing the timing of two standard chemotherapy drugs (gemcitabine and nab-paclitaxel) can improve treatment for pancreatic cancer that has spread. The goal is to see if this adjusted schedule helps shrink tumors better and is tolerable for patients…
Phase: PHASE2 • Sponsor: Anne Noonan • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC